본문 바로가기
타이틀
메뉴
ABOUT
Mission and Values
History
Leadership
Contact
OUR SCIENCE
G-SMART Platform
Kinase Background
PIPELINE
Overview
Lazertinib
Cevidoplenib
ROCK2 inhibitor
TGD/MGD Program
INVESTORS
News
IR/PR Materials
IR Contact
ENG
KOR
ABOUT
Mission and Values
History
Leadership
Contact
OUR SCIENCE
G-SMART Platform
Kinase Background
PIPELINE
Overview
Lazertinib
Cevidoplenib
ROCK2 inhibitor
TGD/MGD Program
INVESTORS
News
IR/PR Materials
IR Contact
INVESTORS
We operate with trust and do the right thing
IR/PR Materials
All
IR/PR
Publications
Apr 03, 2014
IR/PR
Blood: G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia
1
2
3
